ML is poised to become faster and more accessible by 2026. Simply having the support of GenAI already gives it an advantage over other AI-based solutions.
In a recent review posted to the medRxiv* preprint server, scientists explore the utility of machine learning methods in the field of neurodegenerative disease diagnosis, prognosis, and treatment ...